These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32384878)

  • 1. Care management of patients with high cardiovascular risk in Hungary an international and Hungarian longitudinal comparison of target level achievement.
    Jancsó Z; Rurik I; Kolozsvári L; Mester L; Nánási A; Oláh C; Ungvári T; TCs KV; Kalabay L; Torzsa P
    BMC Fam Pract; 2020 May; 21(1):83. PubMed ID: 32384878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk management: the success of target level achievement in high- and very high-risk patients in Hungary.
    Jancsó Z; Csenteri O; Szőllősi GJ; Vajer P; Andréka P
    BMC Prim Care; 2022 Nov; 23(1):305. PubMed ID: 36447162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary care of patients with high cardiovascular risk : Blood pressure, lipid and diabetic target levels and their achievement in Hungary.
    Szigethy E; Jancsó Z; Móczár C; Ilyés I; Kovács E; Róbert Kolozsvári L; Rurik I
    Wien Klin Wochenschr; 2013 Jul; 125(13-14):371-80. PubMed ID: 23824265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.
    Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators
    Eur J Prev Cardiol; 2016 Dec; 23(18):2007-2018. PubMed ID: 27638542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring quality of care and social inequalities related to type 2 diabetes in Hungary: Nationwide representative survey.
    Nagy A; Kovács N; Pálinkás A; Sipos V; Vincze F; Szőllősi G; Csenteri O; Ádány R; Sándor J
    Prim Care Diabetes; 2018 Jun; 12(3):199-211. PubMed ID: 29326023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
    Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
    Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lifestyle and risk factor management in people at high cardiovascular risk from Bulgaria, Croatia, Poland, Romania and the United Kingdom who participated in both the EUROASPIRE III and IV primary care surveys.
    De Backer G; De Bacquer D; Rydén L; Kotseva K; Gaita D; Georgiev B; Gotcheva N; Mancas S; Miličić D; Pająk A; Reiner Ž; Wood D;
    Eur J Prev Cardiol; 2016 Oct; 23(15):1618-27. PubMed ID: 27084894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Data on secondary prevention of coronary artery disease in Hungary and some changes in the last ten years (EUROASPIRE 1995-2005)].
    Jánosi A; Ostör E; Borbás S; Kazinczy R; Káli A; Vámos I; Bradák A; Podmaniczky M
    Orv Hetil; 2010 Oct; 151(43):1776-82. PubMed ID: 20940117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of cardiometabolic risk reduction in patients with type 1 diabetes mellitus].
    Nádas J; Putz Z; Fövényi J; Gaál Z; Gyimesi A; Hídvégi T; Hosszúfalusi N; Neuwirth G; Oroszlán T; Pánczél P; Vándorfi G; Winkler G; Wittmann I; Jermendy G
    Orv Hetil; 2008 Jul; 149(27):1263-9. PubMed ID: 18579465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.
    Ji L; Hu D; Pan C; Weng J; Huo Y; Ma C; Mu Y; Hao C; Ji Q; Ran X; Su B; Zhuo H; Fox KA; Weber M; Zhang D; ;
    Am J Med; 2013 Oct; 126(10):925.e11-22. PubMed ID: 23810406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenge of cardiovascular prevention in primary care: achievement of lifestyle, blood pressure, lipids and diabetes targets for primary prevention in England - results from ASPIRE-3-PREVENT cross-sectional survey.
    Kotseva K; Jennings C; Bassett P; Adamska A; Hobbs R; Wood D;
    Open Heart; 2024 Oct; 11(2):. PubMed ID: 39414309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries.
    Kotseva K; De Backer G; De Bacquer D; Rydén L; Hoes A; Grobbee D; Maggioni A; Marques-Vidal P; Jennings C; Abreu A; Aguiar C; Badariene J; Bruthans J; Cifkova R; Davletov K; Dilic M; Dolzhenko M; Gaita D; Gotcheva N; Hasan-Ali H; Jankowski P; Lionis C; Mancas S; Milićić D; Mirrakhimov E; Oganov R; Pogosova N; Reiner Ž; Vulić D; Wood D;
    Eur J Prev Cardiol; 2021 May; 28(4):370-379. PubMed ID: 33966079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical cardiovascular risk factors in Trinidadian patients with type 2 diabetes mellitus are not influenced by the level of plasma glycaemia.
    Ezenwaka CE; Offiah NV
    West Indian Med J; 2001 Dec; 50(4):288-93. PubMed ID: 11993019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Prevention of Cardiovascular Risk in Lithuania-Results from EUROASPIRE V Survey.
    Urbonas G; Vencevičienė L; Valius L; Krivickienė I; Petrauskas L; Lazarenkienė G; Karpavičienė J; Briedė G; Žučenkienė E; Vencevičius K
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32197516
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetes control in type 2 diabetic subjects treated in primary health care--how far is from life to standards?].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2008; 65(6):277-82. PubMed ID: 18853658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achievement of cardiovascular risk factor targets according to sex and previous history of cardiovascular disease in type 2 diabetes: A population-based study.
    Galbete A; Cambra K; Forga L; Baquedano FJ; Aizpuru F; Lecea O; Librero J; Ibáñez B
    J Diabetes Complications; 2019 Dec; 33(12):107445. PubMed ID: 31668588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attainment of goals from national guidelines among persons with type 2 diabetes: a cohort study in an academic family medicine setting.
    Kirk JK; Huber KR; Clinch CR
    N C Med J; 2005; 66(6):415-9. PubMed ID: 16438097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.